Vital Pharmaceuticals, Inc.

CourtUnited States Bankruptcy Court, S.D. Florida.
DecidedDecember 27, 2022
Docket22-17842
StatusUnknown

This text of Vital Pharmaceuticals, Inc. (Vital Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. Florida. primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vital Pharmaceuticals, Inc., (Fla. 2022).

Opinion

Sr Ma, OY & x □□ OW ae if * □□ iL Ss eA □□□ a Ways A swillikg & \ oh Ai a a8

ORDERED in the Southern District of Florida on December 27, 2022.

Peter D. Russin, Judge United States Bankruptcy Court

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA FORT LAUDERDALE DIVISION

In re: Vital Pharmaceuticals, Inc., et al., Case No. 22-17842-PDR Debtors. Chapter 11 (Jointly Administered) ee ORDER DENYING JOINT MOTION TO APPOINT CREDITORS COMMITTEE Monster Energy (“Monster”), Orange Bang (“Orange”), The American Bottling Company (“ABC”), Sony Music Entertainment (“Sony”), and UMG Recordings (UMG") (together, “Movants”) filed their Joint Motion to Appoint Creditors Committee (Doc. 408) seeking the appointment of a second unsecured creditors committee pursuant to § 1102(a)(2) (the “Motion”). Numerous interested parties

objected to the Motion including the Debtors,1 the Committee,2 the U.S. Trustee,3 and Truist Bank (the “Objectors”).4 The Court conducted an evidentiary hearing on the Motion on December 19, 2022. For the reasons that follow, the Motion is DENIED.

JURISDICTION AND VENUE

The Court has subject matter jurisdiction pursuant to 28 U.S.C. § 1334(b). The Court has statutory authority to hear and determine this case under 28 U.S.C. §157(b)(2)(A) and the general order of reference from the United States District Court for the Southern District of Florida. S.D. Fla. Local Rule 87.2(a). Venue is proper under 28 U.S.C. § 1408. BACKGROUND5 Debtors (the “Debtors” or the “Company”) are in the beverage industry and produce, among other products, the Bang energy drink. Prior to the filing of this jointly administered Chapter 11 case, the Debtors were involved in a significant number of disputes which were the subject of either active or threatened litigation. The Debtors assert in the Declaration of John C. DiDonato in Support of Chapter 11 Petitions6 that notable litigation matters included (i) arbitration with Orange7

1 (Doc. 501).

2 (Doc. 500).

3 (Docs. 466 and 502).

4 (Doc. 499).

5 This Order constitutes the Court’s findings of fact and conclusions of law pursuant to Federal Rule of Bankruptcy Procedure 7052.

6 (Doc. 26).

7 (Doc. 26 at 14). ultimately resulting in Orange obtaining a $175 million disgorgement of profits award on its trademark infringement claim and a royalty payment equal to 5% of net sales of BANG-branded beverages plus $9.3 million in fees and costs and other relief

(the “OBI Judgment”), which the Debtor appealed; and (ii) litigation by Monster for false advertising,8 alleged trade secret misappropriation, alleged violation of the Federal Computer Fraud and Abuse Act, and alleged interference with Monster contracts for retail shelf space, pursuant to which a jury awarded Monster approximately $293 million in damages (the “FAA Verdict”), which Debtor intends to appeal.

Mr. DiDonato further explains that this bankruptcy case was filed in order to (a) obtain “breathing room” from pending litigation, including the OBI Judgment and FAA Verdict, as well as consequences of pending defaults under the Prepetition Credit Agreement; (b) obtain an essential infusion of liquidity totaling $100 million to help stabilize the Company’s operations at a critical juncture in the Company’s business cycle (i.e., on the precipice of launching its new distribution network) through the DIP Facility; and (c) pursue a recapitalization, a replacement financing,

or other transaction that will result in the payment in full of the Company’s outstanding obligations under the Prepetition Credit Agreement and position the Company for success upon its emergence from chapter 11.9

8 (Doc. 26 at 15).

9 (Doc. 26 at 16). On November 1, 2022, the U.S. Trustee appointed an Official Unsecured Creditors Committee, consisting of seven members10 all of whom are alleged by Movants to be trade creditors who did not adequately represent the interests of non-

trade creditors, including themselves. Specifically, Movants assert that each of their claims and many others arose from litigation against the Debtors and are therefore distinct from trade creditor claims. After receiving this type of feedback, the U.S. Trustee reconstituted the Committee to include the following 11 creditors: Proof of Claim # Original Committee Claim Origin (In Millions) Members 1 Stellar Group, Inc. Trade and Litigation Claims Not Yet Filed (Scheduled $18.88) 2 Archer Daniels Midland Co. Trade Creditor $1.14 3 Trinity Logistics, Inc. Trade Creditor $5.74 4 Ardagh Metal Packaging USA Trade and Litigation Claims $11.39 Corp. 5 Crown Cork & Seal USA, Inc. Trade Creditor $13.76 6 QuikTrip Corporation Trade Creditor Not Yet Filed (Scheduled $0.46) 7 XPO Logistics, L.L.C. Trade Creditor $1.94 Members Added to Claim Origin Proof of Claim Reconstituted Committee (In Millions) 8 Warner Music Group Corp Litigation Creditor $28 (Resigned) 9 PepsiCo., Inc. Litigation Creditor Not Yet Filed (Scheduled $115) 10 The American Bottling Co., Trade and Litigation Claims $225 Inc. (“ABC”) (Resigned)

10 (Doc. 245). 11 Harvath Law Group, L.L.C. Litigation Creditor $400 (Uncertified Consumer Class Action claims)

After their appointment, two members, Warner and ABC, resigned from the Committee, citing the fact that non-trade creditors were in the minority.11 Those Movants who were not appointed to the Committee assert the following Litigation Claims12: • Monster Energy: $389.74 Million • Orange Bang: $87 Million • Sony Music Entertainment: $35.5 Million • UMG Recordings: $22.15 Million

ANALYSIS Movants seek the appointment of a second committee under 11 U.S.C. §1102(a)(2), which provides: On request of a party in interest, the court may order the appointment of additional committees of creditors or of equity security holders if necessary to assure adequate representation of creditors or of equity security holders. The United States trustee shall appoint any such committee. The “burden of demonstrating the need for adequate representation under [§ 1102(a)(2)] is borne, in the first instance, by the party seeking appointment.” Albero v. Johns-Manville Corp. (In re Johns-Manville Corp.), 68 B.R. 155, 158 (S.D.N.Y. 1986). The appointment of an additional committee under § 1102 is an extraordinary remedy. In re Winn-Dixie Stores, Inc., 326 B.R. 853, 858 (Bankr. M.D. Fla. 2005); In

11 (Doc. 408 ¶ 5).

12 (Doc. 408 ¶ 2). re Residential Capital, Inc., 480 B.R. 550, 557 (Bankr. S.D.N.Y. 2012); In re Enron Corp., 279 B.R. 671, 685 (Bankr. S.D.N.Y. 2002) (“Ordering the appointment of additional committees, particularly given that the matter is often first reviewed and

addressed by the U.S. Trustee, is an extraordinary remedy.”). Movants’ main argument as to the Committee’s inadequacy of representation is summarized by the following excerpts from the Motion:13 ABC has declined its appointment to a Committee in which non-trade creditors would be in the minority [and likewise] Warner Music, a litigation claimant [ ] has indicated that, like ABC, it is not inclined to sit on a committee in which non-trade creditors are in the minority. . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Woods v. City Nat. Bank & Trust Co. of Chicago
312 U.S. 262 (Supreme Court, 1941)
In The Matter Of The Bohack Corporation
607 F.2d 258 (Second Circuit, 1979)
In Re Dana Corp.
344 B.R. 35 (S.D. New York, 2006)
In Re Beker Industries Corp.
55 B.R. 945 (S.D. New York, 1985)
In Re Enron Corp.
279 B.R. 671 (S.D. New York, 2002)
In Re Winn-Dixie Stores, Inc.
326 B.R. 853 (M.D. Florida, 2005)
In Re Hills Stores Co.
137 B.R. 4 (S.D. New York, 1992)
In Re Sharon Steel Corp.
100 B.R. 767 (W.D. Pennsylvania, 1989)
Matter of Celotex Corp.
123 B.R. 917 (M.D. Florida, 1991)
In Re Nationwide Sports Distributors, Inc.
227 B.R. 455 (E.D. Pennsylvania, 1998)
In Re Wang Laboratories, Inc.
149 B.R. 1 (D. Massachusetts, 1992)
In Re Dow Corning Corp.
194 B.R. 121 (E.D. Michigan, 1996)
In Re Seaescape Cruises, Ltd.
131 B.R. 241 (S.D. Florida, 1991)
In Re National R v. Holdings, Inc.
390 B.R. 690 (C.D. California, 2008)
In Re ShoreBank Corp.
467 B.R. 156 (N.D. Illinois, 2012)
In re Residential Capital, LLC
480 B.R. 550 (S.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Vital Pharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vital-pharmaceuticals-inc-flsb-2022.